View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Crizanlizumab 5, Sickle Cell Disease, Cycle 1
Protocol-ID: 1728 V1.0 (Mini), CZLZ5, Sickle Cell Disease, C1Indication(s)
- Sickle Cell Disease; ICD-10 D57.0, D57.1, D57.2, D57.8
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.02.2021